This observational study examined the effectiveness of beta-blockers in patients with stable coronary heart disease (CHD), suggesting that their routine use in all stable CHD patients may not be necessary. While beta-blockers significantly reduce mortality and recurrent cardiovascular events in patients with recent myocardial infarction or heart failure, their benefits
